US and Europe Private Company Trends: Strong performance despite global headwinds – executive summary
News Draig Therapeutics Launches with $140m Investment to Advance Next-Generation Therapies for Major Neuropsychiatric Disorders
News ICG invests a further £4m to continue flagship educational opportunity and social mobility programme